PGNX - Progenics Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts6665
Avg. Estimate-0.18-0.15-0.61-0.13
Low Estimate-0.23-0.17-0.68-0.59
High Estimate-0.16-0.13-0.470.56
Year Ago EPS-0.2-0.3-0.87-0.61
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts6665
Avg. Estimate6.63M9.31M37.93M88.88M
Low Estimate5.44M7.2M31.4M52.57M
High Estimate9M11.5M49.24M156.49M
Year Ago Sales3.88M5.32M15.62M37.93M
Sales Growth (year/est)71.00%75.10%142.80%134.30%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.19-0.18-0.11-0.19
EPS Actual-0.2-0.3-0.17-0.22
Difference-0.01-0.12-0.06-0.03
Surprise %-5.30%-66.70%-54.50%-15.80%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.18-0.15-0.61-0.13
7 Days Ago-0.18-0.15-0.61-0.13
30 Days Ago-0.19-0.15-0.56-0.12
60 Days Ago-0.19-0.15-0.56-0.12
90 Days Ago-0.1-0.07-0.34-0.24
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1243
Growth EstimatesPGNXIndustrySectorS&P 500
Current Qtr.10.00%N/AN/A0.02
Next Qtr.50.00%N/AN/A0.04
Current Year29.90%N/AN/A0.05
Next Year78.70%N/AN/A0.11
Next 5 Years (per annum)296.40%N/AN/A0.10
Past 5 Years (per annum)-16.22%N/AN/AN/A